These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 19642149)

  • 41. Managing the challenge of atrial fibrillation and stroke prevention in older people: new drugs or new approaches to improve outcomes?
    Fuller R; Dudley N
    Age Ageing; 2005 Jul; 34(4):413-4; author reply 414. PubMed ID: 15955767
    [No Abstract]   [Full Text] [Related]  

  • 42. [New international guidelines on antithrombotic therapy in atrial fibrillation].
    Tveit A
    Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1332-5. PubMed ID: 19561659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

  • 44. [Several alternatives for stroke prophylaxis in atrial fibrillation].
    Olsson SB
    Lakartidningen; 2004 Oct; 101(41):3156, 3158-9. PubMed ID: 15517711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonpharmacologic stroke prevention in atrial fibrillation.
    Onalan O; Lashevsky I; Hamad A; Crystal E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The choice of aspirin dose for primary prevention of embolic complications of nonvalvular atrial fibrillation in elderly people.
    Jolobe OM
    J Am Geriatr Soc; 2009 Jan; 57(1):172-3. PubMed ID: 19170796
    [No Abstract]   [Full Text] [Related]  

  • 47. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 48. The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?
    Karthikeyan G; Eikelboom JW
    Thromb Haemost; 2010 Jul; 104(1):45-8. PubMed ID: 20458437
    [No Abstract]   [Full Text] [Related]  

  • 49. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing stroke risk in patients with AF.
    Marshall G; Rankin AC
    Practitioner; 2007 Jun; 251(1695):30, 33-4, 36 passim. PubMed ID: 17654873
    [No Abstract]   [Full Text] [Related]  

  • 51. [Prevention of embolic heart complications in atrial fibrillation: possibilities of using rivaroxaban].
    Iavelov IS
    Ter Arkh; 2013; 85(12):119-26. PubMed ID: 24640681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcatheter occlusion of the left atrial appendage for stroke prevention.
    Bayard YL; Ostermayer SH; Sievert H
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1003-8. PubMed ID: 16292991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stroke prevention in atrial fibrillation and other major cardiac sources of embolism.
    Freeman WD; Aguilar MI
    Neurol Clin; 2008 Nov; 26(4):1129-60, x-xi. PubMed ID: 19026905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Between Scylla and Charybdis].
    Brean A
    Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1322. PubMed ID: 19561655
    [No Abstract]   [Full Text] [Related]  

  • 57. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
    Bungard TJ; Ghali WA; McAlister FA; Buchan AM; Cave AJ; Hamilton PG; Mitchell LB; Shuaib A; Teo KK; Tsuyuki RT
    CMAJ; 2001 Aug; 165(3):301-2. PubMed ID: 11517646
    [No Abstract]   [Full Text] [Related]  

  • 58. Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation.
    Ramondo A; Maiolino G; Napodano M; Isabella G; Tarantini G; Bonato R; Pengo V; Ponchia A; Iliceto S
    Ital Heart J; 2005 May; 6(5):414-7. PubMed ID: 15934416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. More questions than answers for stroke prevention in the elderly with AF.
    Shiach C
    Age Ageing; 2005 Jan; 34(1):91-2. PubMed ID: 15591492
    [No Abstract]   [Full Text] [Related]  

  • 60. Does long-term warfarin affect the quality of life of older people?
    Das AK; Willcoxson P; Corrado OJ
    Age Ageing; 2005 May; 34(3):312-3. PubMed ID: 15863424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.